This is a knockout-validated antibody summary, based on the publication "FOXC1-induced non-canonical WNT5A-MMP7 signaling regulates invasiveness in triple-negative breast cancer", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).
Rat monoclonal IgG2A
Company: R&D Systems
Antibody: Wnt-5a
Catalog number: MAB645
Summary: Rat monoclonal IgG2A against recombinant mouse Wnt-5a
Gln38-Lys380. Reacts with human and mouse. Suitable for western blot and immunohistochemistry.
Western blot
Control and WNT5A-KO MDA-MB-231 cells.
1:300 dilution.
Western blotting analysis of WNT5A protein in different groups of MDA-MB-231 cells. Actin was used as an internal control. Please see Figure S1d in the article [1].
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.